Last edition
News about "CDMO partnership"
Shilpa Biologicals has launched PartnerPower, a proprietary platform offering real-time visibility into process development and Good Manufacturing Practice (GMP) manufacturing, setting a new benchmark for transparency in CDMO operations.
CDMO Partnership | 24/06/2026 | By News Bureau
Shilpa Medicare Signs Long-Term Manufacturing and Development Pact with NXI Therapeutics AG
Shilpa Medicare and NXI Therapeutics AG have entered into a long-term agreement to support development and commercial manufacturing of immunomodulatory therapies, expanding Shilpa’s global CDMO footprint in high-growth biologics and specialty therapeutics.
CDMO Partnership | 14/05/2026 | By News Bureau | 109
Neuland Laboratories partnership with LIR Life Sciences Corp will focus on developing and manufacturing cell-penetrating peptides to support LIR Life’s patch-based GLP-1/GIP obesity treatment platform.
CDMO Partnership | 07/05/2026 | By News Bureau | 137
Novelty Nobility Partners with AGC Biologics to Advance Bispecific Drug Candidate
Novelty Nobility partners with AGC Biologics to advance a bispecific Antibody Drug Candidate (ADC) into GMP manufacturing, showcasing Japan’s bioprocessing expertise and AGC Biologics’ global development network.
CDMO Partnership | 04/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy